Numerous plaintiffs are filing Zantac and ranitidine lawsuit alleging that the drugs contained unsafe levels of N-Nitrosodimethylamine (NDMA), a probable carcinogen that caused them to develop stomach, liver, and bladder cancer.
In February 2020, the United States Judicial Panel on Multidistrict Litigation consolidated the Zantac lawsuits into MDL No. 2924 in the Southern District of Florida. Experts anticipate that the cases could make up “a large litigation.”
The Zantac lawsuits allege that Sanofi and other defendants were aware of the dangers of NDMA in the drug, but failed to properly warn consumers, and demand compensation for those who developed cancer as a result of NDMA exposure. The ranitidine lawsuits argue that the chemical is unstable and can form NDMA when exposed to stomach acids or a substance called nitrite that is found in foods like grilled meat and preserved foods such as bacon and hot dogs.
The U.S. Environmental Protection Agency (EPA) determined that NDMA was an “extremely hazardous substance” as early as the 1980s. Drug makers were aware of this research as far back as 1981. They, however, failed to warn the public and continued to represent that ranitidine products like Zantac did not pose any risks of cancer or other serious health conditions.
April 1, 2020, the FDA requested that the manufacturers of all ranitidine products remove prescription and over-the-counter versions from the market due to public health risk.
With these discoveries and other research by our attorneys, Childers, Schlueter & Smith may be able to help you. If you have been injured after taking Zantac, please give us a call for a free consultation. You can find further information about Zantac right here on our website.